
A combination VEGFR-2 inhibitor plus an anti–PD-L1 agent demonstrated antitumor activity in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.

A combination VEGFR-2 inhibitor plus an anti–PD-L1 agent demonstrated antitumor activity in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.

Cabometyx found to improve median overall survival by 2.2 months in patients with previously treated advanced hepatocellular carcinoma.

There may not be a significant survival benefit from a surgical procedure for gastric cancer.

Median progression-free survival was 5.8 months among patients with HER2-positive gastric cancer who were treated with DS-8201.

Given the crucial role that pharmacists play in promoting and ensuring medication safety, it is important to that they remain educated on common medication errors and ways to prevent them, according to the Institute for Safe Medication Practices.


In this clip, Mathen talks about why he wanted to share his hospital's experience with the technology and how it can potentially help other hospitals approach the implementation process.

At the ASHP Midyear Clinical Meeting and Exhibition, Andrea White, PharmD, Pharmacy Administrative Resident at Texas Children's Hospital, discussed her presentation on Baxter's DoseEdge System, including the implementation process that Texas Children's Hospital underwent to adopt the new technology in their institution and assess the system's benefits.

To ensure the safe infusion of high-alert medications, titrations need to be protected from harmful dosing changes, according to a poster presentation at the 2017 ASHP Midyear Clinical Meeting and Exhibition.

The understood link between diabetes and cardiovascular disease (CVD) has played a key role in shaping clinical trials on diabetes medications, according to a presentation at the American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition.

Dr. Baird said that it is important for pharmacy professionals to embrace these changes in technology, and he offered some advice for how to go about embracing the changes.

Pharmacists at Oklahoma State University Medical Center (OSUMC) are fighting infectious diseases with cutting-edge technology.

In this clip, Baxter Pharmacy Consultant Jason Demuth discusses the importance of building a master library for smart pumps.

Although administering intravenous (IV) medication via smart infusion pumps has led to improvements in patient safety, common errors persist with the use of these devices, according to a presentation at the American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition.

At the ASHP Midyear 2017 meeting, Amy Westmoreland, pharmacy manager and clinical pharmacist at Carilion Giles Community Hospital discusses the importance of collaboration between hospital pharmacists and physicians.

Current pharmacy technician members of ASHP will be automatically incorporated into the forum.

ASHP officials took time to recognize some of their own.

Several people were honored this week at Baxter Healthcare Corporation’s Leadership Excellence Awards in Pharmacy, or LEAP, ceremony.

ASHP’s 2017 Midyear Clinical Meeting is set to begin, and Pharmacy Times will be on site covering it.

FDA officials discuss safety data and drug approvals at the American College of Rheumatology Annual Meeting.

A significant portion of patients with rheumatoid arthritis may develop cardiovascular disease.

With the growing use of cancer immunotherapies, rheumatologists expect to see more cases of inflammatory conditions.

Patients with osteoarthritis may be able to receive targeted therapy based on phenotypes.

Major adverse cardiovascular event rates for baricitinib stabilize over time.

Methotrexate discontinuation was not observed to impact rheumatoid arthritis treatment with tocilizumab, according to an abstract presented at the 2017 American College of Rheumatology Annual Meeting.

Some patients with rheumatoid arthritis require a refined treat-to-target plan.

Low incidence of 14-3-3η in patients with long-term RA, chronic HCV with arthralgias.

Treatment for psoriatic arthritis may impact symptoms and patient-reported outcomes.

Flares and immune-related adverse events are common among patients with rheumatologic diseases but can often be successfully managed.

Study finds improved mental health resources and non-pharmacologic treatment options may be effective in reducing reduce opioid exposure among children with juvenile fibromyalgia syndrome.